Clinical Trial Update: High Dose Risperidone Consta for Patients With Schizophrenia With Poor Response to Risperidone [Phase 4]

View source ↗

Summary

Phase 4 study evaluating high-dose Risperidone long-acting injectable in schizophrenia patients with poor response to risperidone; the trial is completed with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Risperdal Consta (risperidone long-acting injectable)

Snippet

Sponsor: Northwestern University | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: COMPLETED | Results posted: 2025-08-06